SCHEMBL19082223

SCHEMBL19082223

c1ccc(-c2c3ccccc3c(-c3cccc(-c4c5sc6ccccc6c5cc5c4sc4c6ccccc6ccc54)c3)c3ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.46
CYP1B1 Q16678 5/20 0.46
TNKS O95271 1/20 0.39
TNKS2 Q9H2K2 1/20 0.39
CYP1A2 P05177 3/20 0.38
ALOX5 P09917 1/20 0.36
MAPT P10636 3/20 0.36
F9 P00740 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
ESR1 P03372 3/20 0.33
ESR2 Q92731 3/20 0.33
GPR3 P46089 1/20 0.33
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
RAB9A P51151 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082350 0.94 CYP1A1 (0.42) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL19082155 0.90 CYP1A1 (0.43) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL19082330 0.89 CYP1A1 (0.42) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL19082174 0.88 CYP1A1 (0.40) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL17944619 0.88 TNKS (0.48) TNKSTNKS2ALOX5MAPTF9
SCHEMBL19091586 0.86 CYP1A1 (0.35) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL19082385 0.85 ALOX5 (0.41) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL17247204 0.85 CYP1A1 (0.49) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL19082224 0.84 CYP1A1 (0.41) CYP1A1CYP1B1TNKSTNKS2CYP1A2
SCHEMBL17247206 0.84 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2ALOX5F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885TNKS 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.